229 related articles for article (PubMed ID: 17350363)
1. Frequency of coronary arterial late angiographic stent thrombosis (LAST) in the first six months: outcomes with drug-eluting stents versus bare metal stents.
Park DW; Park SW; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SJ
Am J Cardiol; 2007 Mar; 99(6):774-8. PubMed ID: 17350363
[TBL] [Abstract][Full Text] [Related]
2. Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease.
Park DW; Hong MK; Suh IW; Hwang ES; Lee SW; Jeong YH; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2007 Mar; 99(6):760-5. PubMed ID: 17350360
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis shows similar risk of thrombosis after drug-eluting stent, bare-metal stent, or angioplasty.
Fuchs AT; Kuehnl A; Pelisek J; Rolland PH; Mekkaoui C; Netz H; Nikol S
Endothelium; 2008; 15(1):93-100. PubMed ID: 18568949
[TBL] [Abstract][Full Text] [Related]
4. Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.
Carlsson J; von Wagenheim B; Linder R; Anwari TM; Qvist J; Petersson I; Magounakis T; Lagerqvist B
Clin Res Cardiol; 2007 Feb; 96(2):86-93. PubMed ID: 17180577
[TBL] [Abstract][Full Text] [Related]
5. Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents.
Burzotta F; Siviglia M; Altamura L; Trani C; Leone AM; Romagnoli E; Mazzari MA; Mongiardo R; Niccoli G; Brancati M; Biondi-Zoccai G; Rebuzzi AG; Schiavoni G; Crea F
Am J Cardiol; 2007 Feb; 99(3):364-8. PubMed ID: 17261399
[TBL] [Abstract][Full Text] [Related]
6. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.
Kim YH; Park SW; Lee CW; Hong MK; Gwon HC; Jang Y; Lee MM; Koo BK; Oh DJ; Seung KB; Tahk SJ; Yoon J; Park SJ
Catheter Cardiovasc Interv; 2006 Feb; 67(2):181-7. PubMed ID: 16400663
[TBL] [Abstract][Full Text] [Related]
7. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
[TBL] [Abstract][Full Text] [Related]
8. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
[TBL] [Abstract][Full Text] [Related]
11. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries.
Steinberg DH; Mishra S; Javaid A; Slottow TL; Buch AN; Roy P; Okabe T; Smith KA; Torguson R; Xue Z; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Mar; 99(5):599-602. PubMed ID: 17317356
[TBL] [Abstract][Full Text] [Related]
12. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.
Ong AT; Hoye A; Aoki J; van Mieghem CA; Rodriguez Granillo GA; Sonnenschein K; Regar E; McFadden EP; Sianos G; van der Giessen WJ; de Jaegere PP; de Feyter P; van Domburg RT; Serruys PW
J Am Coll Cardiol; 2005 Mar; 45(6):947-53. PubMed ID: 15766834
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
Wallace EL; Abdel-Latif A; Charnigo R; Moliterno DJ; Brodie B; Matnani R; Ziada KM
Am J Cardiol; 2012 Apr; 109(7):932-40. PubMed ID: 22221949
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Clinical and Angiographic Outcomes After Bare Metal Stents and Drug-Eluting Stents Following Rotational Atherectomy.
Tamura H; Miyauchi K; Dohi T; Tsuboi S; Ogita M; Kasai T; Okai I; Katoh Y; Miyazaki T; Naito R; Konishi H; Yokoyama K; Okazaki S; Isoda K; Kurata T; Daida H
Int Heart J; 2016; 57(2):150-7. PubMed ID: 26973257
[TBL] [Abstract][Full Text] [Related]
15. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
Pfisterer M; Brunner-La Rocca HP; Buser PT; Rickenbacher P; Hunziker P; Mueller C; Jeger R; Bader F; Osswald S; Kaiser C;
J Am Coll Cardiol; 2006 Dec; 48(12):2584-91. PubMed ID: 17174201
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
17. Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients.
Yachi S; Tanabe K; Tanimoto S; Aoki J; Nakazawa G; Yamamoto H; Otsuki S; Yagishita A; Kishi S; Nakano M; Taniwaki M; Sasaki S; Nakajima H; Mise N; Sugimoto T; Hara K
Am J Kidney Dis; 2009 Aug; 54(2):299-306. PubMed ID: 19394736
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
19. Early outcome of treatment of ostial de novo left anterior descending coronary artery lesions with drug-eluting stents.
Tsagalou E; Stankovic G; Iakovou I; Melzi G; Cosgrave J; Ge L; Michev I; Chieffo A; Airoldi F; Carlino M; Montorfano M; Colombo A
Am J Cardiol; 2006 Jan; 97(2):187-91. PubMed ID: 16442360
[TBL] [Abstract][Full Text] [Related]
20. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L;
JACC Cardiovasc Interv; 2015 Oct; 8(12):1552-62. PubMed ID: 26493248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
